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Abstract
A modified magnesium hydrogen breath
test, using end expiratory breath sam-
pling, is described to investigate achlor-
hydria. The efficacy of this test in the
diagnostic investigation of pernicious
anaemia was compared with that ofserum
pepsinogen I. Twenty one patients with
pernicious anaemia - that is, patients
with achlorhydria - and 22 with healed
duodenal ulcer and normal chlorhydria
were studied. Magnesium hydrogen
breath test, serum pepsinogen I, serum
gastrin, and standard gastric acid secre-
tory tests were performed in all subjects.
The mean (SEM) hydrogen peak value
was lower in patients with pernicious
anaemia than in the duodenal ulcer group
(21-7 (1.9) v 71.3 (5.2) ppm; p=0.00005).
The hydrogen peak value had a 95-2%
sensitivity and a 100%/o specificity to detect
pentagastrin resistant achlorhydria.
Mean serum pepsinogen I concentrations
were also significantly lower in patients
with pernicious anaemia than in the
duodenal ulcer group (10.7 (2.7) v 123-6
(11.8) ,g/l p=0.00005). Sensitivity and
specificity to detect pernicious anaemia
were both 1000/% for pepsinogen I. It is
concluded that this modified magnesium
hydrogen breath test is a simple, non-
invasive, cost effective, and accurate
method to assess achlorhydria and may be
useful in the diagnostic investigation of
patients with suspected pernicious
anaemia.
(Gut 1994; 35: 1205-1208)
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Pentagastrin resistant achlorhydria is a
characteristic feature of permicious anaemia.
Its absence rules out this diagnosis. To avoid
gastric intubation and the drawbacks of
traditional gastric secretion tests, some alterna-
tive non-invasive methods, such as technetium-
99m (99mTc) gastric scintigraphyl or the
measurement of serum pepsinogen I concen-
trations,2 have been proposed.
As pepsin and acid secretion both decline
to the point of virtual or complete absence
in atrophic gastritis, the measurement of
serum pepsinogen I had been considered
to be an indirect method to diagnose achlor-
hydria in patients with pernicious anaemia.3
Carmel4 showed the low serum pepsinogen I
concentrations (<30 pKg/l) occurred in 92%
of patients with pernicious anaemia. The
author concluded that serum pepsinogen I
measurement is the most sensitive serum
marker for pernicious anaemia. Pepsinogen I
assay, however, is expensive, requires sophisti-
cated equipment, and qualified personnel.
In 1985, Sack et a15 developed a non-
invasive tubeless method to measure gastric
acid secretion. It was based upon the reaction
of ingested magnesium metal with gastric acid
to produce hydrogen (Fig 1), which was
detected in the exhaled air and belches by gas
chromatography. The technique required
the collection of the total air exhaled into a
120 litre balloon, the measurement of the air
volume, and the calculation of the water
vapour content in each sample. Therefore,
this approach was difficult to use in clinical
practice.
In our study, the magnesium hydrogen
breath test (mgHBT) has been modified
using end expiratory breath sampling, to make
it suitable for clinical use. In addition,
the accuracy of both MgHBT and serum
pepsinogen I for assessing achlorhydria in the
diagnostic investigation of permicious anaemia
have been compared.
Subjects and methods
SUBJECTS
Twenty one patients with pernicious anaemia
(8 male, 13 female; 61 2-8 years mean (SEM)),
and 22 endoscopically proved healed duodenal
ulcer patients with normalchlorhydria (19 male,
3 female; 46'1 (2) years) were included in the
study. The diagnosis of pernicious anaemia
was based upon the finding of low serum
cobalamin concentration, positive Schilling
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Figure 2: ROC curve of hydrogen peak concentration.
test, histologically proved fundal atrophic
gastritis, and pentagastric resistant achlor-
hydria.6 All subjects gave informed consent and
the study protocol was approved by
the research committee of the hospital and
performed in accordance with the Helsinki
Declaration.
PROCEDURES
In duodenal ulcer patients all antisecretory
drugs had been withdrawn one week before
each test. All subjects fasted overnight and
refrained from smoking.
Fasting serum samples for pepsinogen I and
gastric assays were obtained before the
MgHBT and stored at -30°C. Pepsinogen I
and gastrin concentrations were determined by
a competitive binding double antibody
radioimmunoassay (Pepsik, Sorin Biomedica,
Italy; and Gastrin, Diagnostic Products
Corporation. USA).7 8 A pepsinogen I concen-
tration lower than 30 pug/l was considered
suggestive of pernicious anaemia.4 Standard
gastric acid secretory tests were carried out in
all patients. Basal acid output, and peak acid
output after injecting 6 ,uglkg pentagastrin IM
TABLE I Individual values ofpepsinogen I and hydrogen peak in both groups ofpatients
Duodenal ulcer Pernicious anemia
Pepsinogen I Hydrogen peak Pepsinogen I Hydrogen peak
Case no (ng/ml) (ppm) Case no (ng/ml) (Ppm)
1 63-4 52 1 13 30
2 97.3 90 2 0 30
3 148-0 45 3 5 18
4 62-3 87 4 18 8
5 86-9 72 5 0 27
6 135-0 100 6 10-1 29
7 134-0 85 7 4-2 8
8 110-0 48 8 16 22
9 57-2 52 9 12-5 19
10 226-0 86 10 0-1 27
11 212-0 109 11 16-7 17
12 79.3 59 12 5 10
13 247-0 72 13 5.2 25
14 31.7 140 14 10.4 19
15 171.0 68 15 10-3 16
16 120-0 53 16 5-8 20
17 136-0 47 17 11-6 17
18 79-4 43 18 4-8 24
19 128-0 61 19 8-7 17
20 125-0 54 20 7 45
21 118-0 65 21 27 28
22 150-0 80
(Peptavlon, ICI-Farma SA, Spain), were
measured. Normal chlorhydria was defined as a
peak acid output between 8.0 and 60.6 mmol/h.
MgHBT was carried out one week after the
gastric acid analysis. The day before the breath
test, all subjects ate a non-absorbable carbo-
hydrate free diet.9 After a 12 hour overnight
fast, three end expiratory breath samples'0
were obtained (baseline). Thirty minutes
after 6 ,ug/kg pentagastrin IM was given,
subjects swallowed 150 mg of magnesium
metal (0-1-0.3 mm, Art 5815, Merck-Igoda,
Spain) suspended in 10 ml of water, followed
immediately by 100 ml of tap water. In
contrast with Sack's method,5 glucose syrup
was not used to suspend magnesium metal
because it induces breath hydrogen excretion
in achlorhydric patients (unpublished find-
ings), probably because of gastric bacterial
overgrowth.
Twenty ml end expiratory breath samples
were obtained at five minute intervals during
the first hour, and at 10 minute intervals
during the second hour. Belches were collected
if they occurred in a 300 ml bag with an
unidirectional valve. In such cases, 20 ml
samples were obtained from the bag to deter-
mine the hydrogen concentration in each
belch. Patients were seated but awake and
refrained from smoking during the whole test
period.1' Samples were immediately analysed
and the hydrogen concentration measured by
means of hydrogen sensitive conductance
using a Lactoscreen hydrogen analyser (range
0-200 ppm, accuracy +2%, Grifols SA,
Barcelona, under licence of Hoek Loos, The
Netherlands). This method has previously
been shown to have an excellent correlation
with gas chromatography.'2 A hydrogen peak
value above basal excretion c30 ppm was
considered indicative of achlorhydria. A
receiver operating characteristic (ROC) curve
was used to define this cut off value (Fig 2).
In four additional patients with duodenal
ulcers, MgHBT was repeated after 48 hours of
omeprazole treatment (40 mg/day) to assess
the efficacy of the test to evaluate drug induced
achlorhydria.
STATISTICS
Results are expressed as mean (SEM). The
Student's t test or the Mann-Whitney U test
were used to investigate differences between
groups. A p value less than 0.05 was consid-
ered as significant. Sensitivity and specificity of
MgHBT and serum pepsinogen I to detect
achlorhydria were calculated.
Results
Table I and II show the results. Peak acid
output values in duodenal ulcer patients
were within the normal range. As previously
stated, all patients with pernicious anaemia
had a peak acid output value of 0.00 mmol/h.
Mean hydrogen peak values were significantly
higher in duodenal ulcer than in pernicious
anaemia patients. All but one patient with
pernicious anaemia and none with duodenal
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TABLE II Results ofacid secretion studies in both groups ofpatients (mean (SEM))
Pernicious anaemia Duodenal ulcer p Value
Pepsinogen I (,ug/i) 10-7 (2.7) 123-6 (11-8) 0.00005
Gastrin (pg/ml) 777-1 (92-1) 66-2 (11-4) 0 00005
Peak acid output (mmol/h) 0 43 (4.8) 0 00005
Hydrogen peak (ppm) 21-7 (1.9) 71-3 (5.2) 0.00005
ulcer had hydrogen peak values 630 ppm
(Fig 3).
Patients with pernicious anaemia had no
belches during the test, whereas they occurred
in two subjects in the duodenal ulcer group.
No side effects attributable to magnesium were
seen.
As expected, serum pepsinogen I concentra-
tions were significantly lower in pernicious
anaemia than in the duodenal ulcer group
(Table II). Serum gastrin concentrations were
increased in most cases with pernicious anaemia
(above 100 ng/l in 86% of the patients). All
pernicious anaemia patients and none with
duodenal ulcer had serum concentrations of
pepsinogen I lower than 30 ,ug/l (Fig 3).
Sensitivity and specificity to detect achylory-
dria in pernicious anaemia were 95.24% and
100% for MgHBT, whereas they were both
100% for serum pepsinogen I.
Hydrogen peak values decreased consider-
ably in three of four duodenal ulcer patients
after 48 hours of 40 mg omeprazzole treatment
(Fig 4).
Discussion
Various direct and indirect tests are used to
diagnose pernicious anaemia in patients
with megaloblastic anaemia and vitamin B-12
deficiency. These include the Schilling test,
intrinsic factor assay in gastric juice, assay
for anti-parietal cell and anti-intrinsic factor
antibodies, and gastric acid secretion analysis.
Some are expensive because they need
radioisotopes and special equipment, whereas
others are simple but uncomfortable for the
patients and have some drawbacks.6 13 14 The
presence of achlorhydria, however, together
with other elements of the clinical picture,
is considered sufficient for establishing the
diagnosis of pernicious anaemia.6 Accordingly,
non-invasive tests to study gastric acid
secretion have been proposed. 2
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Figure 3: (A) Hydrogen peak (ppm) and (B) serum pepsinogen I (,ug/l) concentrations of
patients with pernicious anaemia (PA) and duoedenal ulcer (DU). Points below the
horizontal line represent achlorhydria.
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Figure 4: Evolution of hydrogen peak in duodenal ulcer
patients after 48 hours of 40 mg omeprazole treatment.
Dotted line represents achlorhydria level.
The measurement of serum pepsinogen I
has been shown to be a non-invasive and sensi-
tive method to detect pernicious anaemia.4 In
this series, the frequency of low concentrations
of serum pepsinogen I in patients with perni-
cious anaemia was similar to that previously
published.4 The analysis of serum pepsinogen
I, however, also requires specific equipment for
radioimmunoassay, not available in all centres.
Another disadvantage of the pepsinogen I
assay is the delay in obtaining the results as, to
reduce costs, the samples cannot be analysed
until enough serum samples are collected to
complete an assay kit.
The modifications of the MgHBT described
in this paper, mainly end expiratory sample
collections, make the test simpler and more
suitable for clinical use than the original Sack's
technique. The equipment for measuring
breath hydrogen by hydrogen sensitive con-
ductance is not expensive and requires little
technical support. It is easy to use and can be
used by non-qualified personnel. On the other
hand, in the light of the results, the study
of spontaneous belches does not seem to be
necessary in patients with either achlorhydria
or normal chlorhydria. In these cases, the
measurement of end expiratory breath samples
is enough to detect the absence or presence of
acid in the stomach.
The cut off value of 630 ppm over the basal
hydrogen excretion was the maximum discrim-
ination point in the ROC curve. The increase
in hydrogen excretion until 30 ppm in patients
with pernicious anaemia may have, at least,
one possible explanation. An early increase in
hydrogen concentration has been described
during a hydrogen breath test because, in part,
of a reflex emptying to the caecum of carbo-
hydrate residues in the ileum from a previous
meal, a manifestation of the so called 'gastro-
ileal reflex'.15 It was shown, however, that the
magnitude of these hydrogen concentration
increments was unlikely to be greater than
20 ppm, ranged from 4 to 31 ppm (median
8 ppm) , and wore off within 60 minutes in
80% of the cases. 16
In this study, hydrogen peak values had a
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high sensitivity and specificity, similar to that
of serum pepsinogen I concentrations, to
detect achlorhydria in patients with pernicious
anaemia. In addition to its practicability, the
MgHBT offers the advantage that the results
are immediately available. For this reason, the
MgHBT could be included in the diagnostic
investigation of the patients with low serum
concentrations of cobalamin, macrocytosis or
unexplained neurological disturbances before
performing other more uncomfortable tests
such as fibregastroscopy or the classic gastric
acid secretion study. On the other hand, the
finding of a low hydrogen peak concentration
in patients with non-conclusive low range
serum cobalamin concentrations (between
100-200 pg/ml) could suggest the existence of
pernicious anaemia in an early stage.
Furthermore, the MgHBT might also be
included in the diagnostic investigation of
anaemias of unexplained origin.
As achlorhydria may precede by many years
fully developed pernicious anaemia,6 the
MgHBT may be useful as a screening tool in
relatives of patients with pernicious anaemia.
An additional use of the MgHBT might
be the assessment of the response to anti-
secretory treatment in acid related diseases. In
this sense, we have also shown that the 48 hour
response to 40 mg oral omeprazole administra-
tion was adequate in only three of four duo-
denal ulcer patients treated. The value of the
MgHBT after omeprazole treatment, however,
needs further study.
It is concluded that the modified MgHBT
using end expiratory sampling is a simple,
non-invasive, cost effective, and accurate
method to assess achlorhydria and may be
useful in the diagnostic investigation of
patients with suspected pernicious anaemia
and for screening of their relatives.
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